Back to Search Start Over

Tumor-infiltrating CD163-positive macrophages and clinical outcomes to first-line nivolumab therapy in patients with advanced clear cell renal cell carcinoma (ccRCC) enrolled in the HCRN GU16-260 trial.

Details

Language :
English
ISSN :
0732183X
Volume :
42
Database :
Supplemental Index
Journal :
Journal of Clinical Oncology
Publication Type :
Academic Journal
Accession number :
175074107
Full Text :
https://doi.org/10.1200/JCO.2024.42.4_suppl.448